Adial Pharmaceuticals Receives $1.2 Million in Proceeds Through the Exercise of Warrants – Nasdaq

Enhances Balance Sheet; Funds to be Utilized for Phase 3 Clinical Trial of AD04. CHARLOTTESVILLE, Va., Jan. 24, 2019 (GLOBE NEWSWIRE) — Adial …